Evidence map›Paper›PMID 41476131›Full record

ArticleNPJ digital medicine2025

Deep multimodal state-space fusion of endoscopic-radiomic and clinical data for survival prediction in colorectal cancer.

Ning Wang, Jiajing Lin, Wujin Li, Yahui Lyu, Yiqing Jiang, Zhizhan Ni, Qi Huang, Hong Chen, Qiang Yan, Chenshen Huang

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ning Wang *Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, Zhejiang, China.
Jiajing Lin *Fuzhou University Affiliated Provincial Hospital, School of Medicine, Fuzhou University, Fuzhou, Fujian, China.
Wujin Li *Fuzhou University Affiliated Provincial Hospital, School of Medicine, Fuzhou University, Fuzhou, Fujian, China.
Yahui Lyu *Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, Zhejiang, China.
Yiqing JiangSchool of Mathematical Sciences, Tongji University, Shanghai, Shanghai, China.
Zhizhan NiSchool of Medicine, Tongji University, Shanghai, Shanghai, China.
Qi HuangSchool of Medicine, Tongji University, Shanghai, Shanghai, China.
Hong ChenFuzhou University Affiliated Provincial Hospital, School of Medicine, Fuzhou University, Fuzhou, Fujian, China. hongruhe@163.com.
Qiang YanHuzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, Zhejiang, China. yianq@hzhospital.com.
Chenshen HuangFuzhou University Affiliated Provincial Hospital, School of Medicine, Fuzhou University, Fuzhou, Fujian, China. chenshenhuang@126.com.

Funding

the Joint Funds for the Innovation of Science and Technology, Fujian Province 2023Y9299
6 · The paper itself

Abstract

Integrating complementary surface and cross sectional cues is central to preoperative assessment of colorectal cancer, but technically challenging because endoscopic images and pelvic CT encode anatomy at different scales. Here we present HydraMamba, a multimodal selective state space framework that fuses endoscopy and CT for joint lesion segmentation, lesion detection, and survival prediction. The model couples a shared state space backbone with two lightweight modules. Across the endoscopic dataset and the CT dataset, HydraMamba achieved state-of-the-art lesion analysis (endoscopy: Dice 0.856, F1 0.918; CT: Dice 0.812, F1 0.888) and delivered calibrated survival modeling on the CT dataset (Harrell's C index 0.832, Uno's C@1y 0.853, integrated Brier score 0.161, calibration slope ≈1.01). By unifying endoscopic and CT information in a single coherent architecture, HydraMamba provides an accurate and well-calibrated foundation for lesion analysis and prognostication in colorectal cancer.

Identifiers

PMID41476131
PMCPMC12756232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.